Bone Biologics Corp.
13F holders, Q2 2024 (June 30)5holders +1
3new positions
2sold out
$1.21avg. 13F price*
At the end of Q2 2024, 5 institutions reported holding Bone Biologics Corp. in their 13F filings, up 1 from Q1 2024. 3 opened new positions and 2 sold out. The largest holders were UBS Group AG ($41K), HRT Financial LP ($21K) and Tower Research Capital LLC (TRC) ($7K).
- Company
- Bone Biologics Corp.
- CUSIP
- 098070501
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $22K |
| Exits | 2 | $79K |
All 13F filers, Q1 2024 → Q2 2024: 52,577 shares bought and 37,004 shares sold, net +15,573 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| UBS Group AG | 0.00% | Add +5517.8% | 33,707 | $41K |
| HRT Financial LP | 0.00% | New | 17,519 | $21K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +36.2% | 5,789 | $7K |
| Mfa Wealth Advisors, LLC | 0.00% | New | 403 | $492 |
| Bank of America Corp. | 0.00% | New | 9 | $11 |
"% of holder's portfolio" is BONE BIOLOGICS CORP's weight in each manager's 13F, not the share of Bone Biologics Corp. the manager owns.